10x Genomics Denmark ApS: Financial statements 2023
CVR: 40243224
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
10x Genomics Denmark ApS (CVR 40243224) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,058,991 and a net result of DKK -586,583 compared with DKK 2,820,214 the year before. That is a decrease of 71.9% compared with the year before. Equity in the 2023 report amounted to DKK 635,339. The solvency ratio was 27.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,058,991
- Profit/Loss
- DKK -586,583
- Equity
- DKK 635,339
- Total Assets
- DKK 2,342,021
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.1 mio. | -587 t. | 635 t. | 2 |
| 2022 | - | 7.3 mio. | 2.8 mio. | 1.2 mio. | 5 |
| 2021 | - | 52.2 mio. | 39.8 mio. | 38.4 mio. | 2 |
| 2020 | - | -1.6 mio. | -2 mio. | -1.4 mio. | 2 |
| 2019 | - | 552 t. | 245 t. | 625 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
10x Genomics Denmark ApS has published its annual report for 2022. Gross profit came to DKK 7,333,851, and the net result was DKK 2,820,214.
About 10x Genomics Denmark ApS
10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.